A. J. Kashimawo, Kemelayefa O. James, N. D. Nnamani
Background and Purpose: Men of age 40 years and above are at risk of non-cancerous enlargement of the prostate gland also known as benign prostatic hyperplasia (BPH). Adverse drug reactions and treatment relapse limit the effectiveness of orthodox pharmacotherapies. This study evaluated the effect of Cassia fistula hydroalcoholic extract on BPH. Methods: BPH was induced in Wistar rats by subcutaneous injection of 10 mg/kg/day of testosterone propionate (TP) for 7 days. The rats were randomly allotted to five groups: corn oil only; finasteride (FS) 5 mg/kg/day; and C. fistula extract at doses of 100, 200, and 400 mg/kg/day. A sixth group in which BPH was not induced received only the vehicle. At the end of 28 consecutive days of treatment, prostate and testicular weights and indices were evaluated. The in vitro antioxidant capacity of the extract was evaluated using the DPPH free radical scavenging method. Results: The extract showed a very strong free radical scavenging activity with IC50 value of 1.58 µg/mL (IC50 of gallic acid = 0.63 µg/mL) due to the presence of secondary metabolites. The results also showed significant (P?0.0001) reduction in the prostate weight, prostatic index, testes weight, and testes index of C. fistula extract-treated rats when compared with the untreated BPH group. Conclusion: These results suggest that C. fistula extract possesses potentials as a remedy for the treatment of BPH.
{"title":"Effect of Cassia fistula Hydroalcoholic Extract on Testosterone Induced Benign Prostatic Hyperplasia in Wistar Rats","authors":"A. J. Kashimawo, Kemelayefa O. James, N. D. Nnamani","doi":"10.52406/ptnm.v1i1.9","DOIUrl":"https://doi.org/10.52406/ptnm.v1i1.9","url":null,"abstract":"Background and Purpose: Men of age 40 years and above are at risk of non-cancerous enlargement of the prostate gland also known as benign prostatic hyperplasia (BPH). Adverse drug reactions and treatment relapse limit the effectiveness of orthodox pharmacotherapies. This study evaluated the effect of Cassia fistula hydroalcoholic extract on BPH. \u0000Methods: BPH was induced in Wistar rats by subcutaneous injection of 10 mg/kg/day of testosterone propionate (TP) for 7 days. The rats were randomly allotted to five groups: corn oil only; finasteride (FS) 5 mg/kg/day; and C. fistula extract at doses of 100, 200, and 400 mg/kg/day. A sixth group in which BPH was not induced received only the vehicle. At the end of 28 consecutive days of treatment, prostate and testicular weights and indices were evaluated. The in vitro antioxidant capacity of the extract was evaluated using the DPPH free radical scavenging method. \u0000Results: The extract showed a very strong free radical scavenging activity with IC50 value of 1.58 µg/mL (IC50 of gallic acid = 0.63 µg/mL) due to the presence of secondary metabolites. The results also showed significant (P?0.0001) reduction in the prostate weight, prostatic index, testes weight, and testes index of C. fistula extract-treated rats when compared with the untreated BPH group. \u0000Conclusion: These results suggest that C. fistula extract possesses potentials as a remedy for the treatment of BPH.","PeriodicalId":104078,"journal":{"name":"Pharmacology and Toxicology of Natural Medicines (ISSN: 2756-6838)","volume":"62 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123209814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. Adeneye, O. Olorundare, A. Akinsola, D. Sanni, J. Ntambi, H. Mukhtar
Background and Purpose: Hepatorenal toxicity is a side effect of the anthracycline cytotoxic antibiotics, doxorubicin that is used in cancer treatment. The study investigated the ameliorative potential of Clerodendrum volubile ethanol leaf extract (CVE) on doxorubicin (DOX)-induced hepatorenal toxicities. Methods: Male Wistar rats were pretreated with Clerodendrum volubile ethanol leaf extract (50 - 400 mg/kg/day, p.o) followed by intraperitoneal injection of 2.5 mg/kg of DOX on alternate days for 14 days. Hepatorenal toxicity was assessed using renal function parameters (serum electrolytes, blood urea and creatinine), hepatic function endpoints [aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP), total protein (TP), albumin (ALB) and total bilirubin (TB)]. In addition, the antioxidant activity in the kidney and liver tissues were assayed and histological studies of these tissues were also conducted. Results: Oral pretreatment with 50 mg/kg/day, 100 mg/kg/day, 200 mg/kg/day and 400 mg/kg/day of CVE remarkably ameliorated DOX-induced liver and kidney injury by lowering the serum ALT, AST, ALP, Cr and BUN levels. CVE pretreatment remarkably ameliorated DOX-induced increases in the CAT, SOD and GPx activities and MDA levels compared to the DOX-treated rats. The biochemical changes were corroborated by improvements in the DOX-induced histological lesions seen in the hepatic and renal tissues examined. Conclusions: Overall, these findings suggest that Clerodendrum volubile ethanol leaf extract elicits protective effect against DOX-induced hepatorenal toxicities mediated primarily via oxidative stress suppression and improvement in the free radicals scavenging activities of CVE.
{"title":"Ameliorative Potential of Clerodendrum volubile Ethanol Leaf Extract on Doxorubicin-Induced Hepatorenal Toxicities in Rats","authors":"A. Adeneye, O. Olorundare, A. Akinsola, D. Sanni, J. Ntambi, H. Mukhtar","doi":"10.52406/ptnm.v1i1.8","DOIUrl":"https://doi.org/10.52406/ptnm.v1i1.8","url":null,"abstract":"Background and Purpose: Hepatorenal toxicity is a side effect of the anthracycline cytotoxic antibiotics, doxorubicin that is used in cancer treatment. The study investigated the ameliorative potential of Clerodendrum volubile ethanol leaf extract (CVE) on doxorubicin (DOX)-induced hepatorenal toxicities. \u0000Methods: Male Wistar rats were pretreated with Clerodendrum volubile ethanol leaf extract (50 - 400 mg/kg/day, p.o) followed by intraperitoneal injection of 2.5 mg/kg of DOX on alternate days for 14 days. Hepatorenal toxicity was assessed using renal function parameters (serum electrolytes, blood urea and creatinine), hepatic function endpoints [aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase (ALP), total protein (TP), albumin (ALB) and total bilirubin (TB)]. In addition, the antioxidant activity in the kidney and liver tissues were assayed and histological studies of these tissues were also conducted. \u0000Results: Oral pretreatment with 50 mg/kg/day, 100 mg/kg/day, 200 mg/kg/day and 400 mg/kg/day of CVE remarkably ameliorated DOX-induced liver and kidney injury by lowering the serum ALT, AST, ALP, Cr and BUN levels. CVE pretreatment remarkably ameliorated DOX-induced increases in the CAT, SOD and GPx activities and MDA levels compared to the DOX-treated rats. The biochemical changes were corroborated by improvements in the DOX-induced histological lesions seen in the hepatic and renal tissues examined. \u0000Conclusions: Overall, these findings suggest that Clerodendrum volubile ethanol leaf extract elicits protective effect against DOX-induced hepatorenal toxicities mediated primarily via oxidative stress suppression and improvement in the free radicals scavenging activities of CVE.","PeriodicalId":104078,"journal":{"name":"Pharmacology and Toxicology of Natural Medicines (ISSN: 2756-6838)","volume":"50 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2021-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127072848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：